Skip to main content
. 2019 Jun 19;10:1361. doi: 10.3389/fimmu.2019.01361

Figure 5.

Figure 5

Effect of IL-33 on mast cell degranulation by FcεRI crosslinking. CBMCs were treated with 10 ng/ml IL-33 for 1 h (A,C) or repeatedly every day for 4 days (B,D); thereafter, they were stimulated various concentrations of anti-IgE. Degranulation was measured by the detection of surface CD63 with flow cytometry (A,B) or as histamine release (C,D). Data shown were pooled from 3 independent experiments, n = 3.